Which statement about ranolazine (Ranexa) , a fatty oxidase enzyme inhibitor, is true?
A) It causes coronary artery vasodilation.
B) It causes no gastrointestinal side effects.
C) It causes QT interval prolongation.
D) It elevates LDL levels.
Correct Answer:
Verified
Q1: The nurse is teaching a patient about
Q5: How do beta-adrenergic blocking agents reduce myocardial
Q7: What risk is minimized when the smallest
Q7: Which therapies are used in the treatment
Q8: When are sustained-release nitroglycerin tablets administered?
A) Once
Q9: How frequently are nitroglycerin tablets discarded and
Q10: Which medication combinations may be beneficial in
Q12: Which instruction will the nurse include for
Q17: The nurse is performing pain assessment on
Q18: Which statement is true regarding the pain
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents